Successful treatment of acute prostatitis caused by multidrug-resistant Escherichia coli with tigecycline monotherapy

Elia Lo Priore, David M. Livermore, Niccolo Buetti, Philipp Jent, Niklas Pelzer, Carlo Casanova, Hansjakob Furrer, Baharak Babouee Flury

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)
20 Downloads (Pure)

Abstract

We present a successful treatment, with tigecycline monotherapy, of acute prostatitis caused by multidrug-resistant Escherichia coli harboring an NDM-1 carbapemenase along with a CMY-2 cephalosporinase and a TEM ESBL.

Original languageEnglish
Article numberofz551
JournalOpen Forum Infectious Diseases
Volume7
Issue number1
Early online date9 Jan 2020
DOIs
Publication statusPublished - Jan 2020

Keywords

  • CMY-2
  • EFFICACY
  • INFECTIONS
  • NDM-1
  • PHASE-3
  • SAFETY
  • TEM ESBL
  • prostatitis
  • tigecyclin

Cite this